We are live on ! Find out more
BVXVW

BiondVax Pharmaceuticals Ltd.
BVXVW

Delisted

BVXVW was delisted on the 13th of May, 2020.

Back to rankings

2 hedge funds and large institutions have $101K invested in BiondVax Pharmaceuticals Ltd. in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

18% less capital invested

Capital invested by funds: $123K → $101K (-$22K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$106K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$87K +$113K +72,800 New
VIA
2
Vantage Investment Advisors
Pennsylvania
$14K – – –
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
– -$106K -72,800 Closed

BVXVW Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in BiondVax Pharmaceuticals Ltd. (BVXVW) for Q1 2018, worth a combined $101K — down 18% from $123K a quarter earlier.

Fund positioning in BVXVW was balanced in Q1 2018: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $106K sold.

  • 2 institutional investors held BiondVax Pharmaceuticals Ltd. (BVXVW) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $101K of BiondVax Pharmaceuticals Ltd. stock for Q1 2018, down 18% quarter-over-quarter.
  • 1 fund opened new BiondVax Pharmaceuticals Ltd. positions in Q1 2018 and 1 closed out, a net change of 0 holders.
  • The largest BiondVax Pharmaceuticals Ltd. seller in Q1 2018 was Susquehanna International Group, an estimated $106K sold.

Based on aggregated 13F filings for Q1 2018.